2024 ASCO Direct™ Michigan

Learn How to Claim Your Credit

Total Health's 2024 ASCO Direct™ Michigan Conference is an officially licensed  ASCO Direct meeting. This Post ASCO Review showcases abstracts from highly rated presentations, allowing attendees to engage with the latest research and strategies in oncology education. This accredited meeting will be hosted as an in-person conference with on-demand access for registered attendees.

Event Page

Accreditation Information | 7.25

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

• Nurses (ANCC) Credit Designation

  Amedco LLC designates this activity for a maximum of 7.25 ANCC contact hours.

• Physicians (ACCME) Credit Designation

  Amedco LLC designates this live activity for a maximum of 7.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

• Pharmacists and Pharmacy Technicians (ACPE) Credit Designation

  Amedco LLC designates this activity for a maximum of 7.25 knowledge-based CPE contact hours.

  NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.

• Learners Notification

  Learner Notification

  Objectives - After Attending This Program You Should Be Able To

  1. Integrate new evidence into everyday clinical practice, thereby improving the quality of care being delivered to patients living with and beyond cancer.

  2. Implement practice changes in a variety of treatment options for solid tumors, including lung, breast, melanoma, colorectal, non-colorectal GI, and GU cancers.

  3. Stimulate innovative strategies for new and additional research related to treatment and prevention.

  Disclosure of Conflict of Interest

  The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-6.2, 6.5)

  All individuals in a position to control the content of CE are listed below.

  Name Commercial Interest:Relationship

  Nagla Abdel Karim | Regeneron, sanofi:Speakers Bureau Exelixis:Research Grant Site Principal Investigator Genentech, Astra Zeneca, Novo cure:Scientific/Medical Advisory Board Member

  Pedro Barata | Merck, Eisai, EMD Serono, Pfizer, Caris Life Sciences, AstraZeneca, Exelixis, Bayer:Consultant UroToday, Targeted Oncology :Scientific/Medical Advisory Board Member

  Nan Chen | Stemline Therapeutics, Guardant Health, Seagen:Consultant Eli Lilly:Research Grant Site Principal Investigator

  Kristen Ciombor | Merck, Pfizer, Seagen:Consultant Lilly/Loxo, Replimune, Personalis:Scientific/Medical Advisory Board Member BMS, Daiichi Sankyo, Nucana, Merck, Pfizer:Research Grant Site Principal Investigator; Incyte:Research Grant Overall Principal Investigator, ALC Oncology, Tempus: Consultant

  Jorge Cortes | Pfizer, Novartis, Takeda, SunPharma, Biopath Holdings:Consultant

  Adil Daud | Merck, BMS, Pfizer, Roche, Incyte, Oncosec, Checkmate:Research Grant Site Principal Investigator Trex:Stock Shareholder IQvia:Consultant

  Abhinav Deol NA

  Shatha Farhan NA

  Hamza Hashmi NA

  Elyse Lower | Seagen:Speakers BureauBiotheranostics:Scientific/Medical Advisory Board Member

  Molly MacDonald NA

  Sami Mansfield NA

  Melissa Reimers | Astra Zeneca, Bristol Myers Squibb, CRISPR Therapeutics, Eisai, Forma Therapeutics, Genentech, Janssen, Loxo, Merck, Profound Bio:Research Grant Site Principal Investigator Genentech, Loxo:Scientific/Medical Advisory Board Member

  Wasif Saif NA

  Victoria M. Villaflor | Gilead, AstraZeneca, Novocure, Bristol Myers Squibb, Regeneron, Daiichi Sankyo:Consultant TGen:Research Grant Overall Principal Investigator

  Antoinette Wozniak | AstraZeneca:Consultant Epic:Other

  Reyna Wilhelm NA

  Justin Kaiser NA

How to Get Your Certificate

1. Go to thc.cmecertificateonline.com

2. Click on the ASCO Michigan 2024 link.

3. For ABIM MOC click on the ASCO Michigan 2024 ABIM MOC link.

4. Evaluate the meeting.

5. Print, download, or save your certificate for your records.

6. If you lose your certificate, or need help, go to help.cmecertificateonline.com